Skip to content

Pathology Foundation Models — Faisal Mahmood (Harvard / Mahmood Lab)

ISBI 2026 plenary keynote on pathology foundation models, slide-level aggregation, and multimodal pathology agents — the methods-side bridge from the AACR pathology-FM dossier line (CHIEF / UNI / Prov-GigaPath) into the IEEE imaging community.

  • Speaker(s) / Authors: Faisal Mahmood
  • Affiliation(s): Harvard Medical School / Brigham & Women's Hospital / Broad Institute (Mahmood Lab)
  • Anchor type: keynote
  • Track / day: ISBI 2026 main plenary (Thu Apr 9 or Fri Apr 10, ExCeL London)
  • IEEE Xplore: TBD (keynote — no IEEE Xplore paper; any new artifact tracked via Mahmood Lab GitHub / HuggingFace through Q2 2026)
  • Status: post-meeting

What it does

Mahmood's keynote framed the current pathology-FM landscape — CHIEF (slide-level diagnostic + prognostic FM), UNI / UNI2 (tile-level encoder pretrained on >100M H&E patches), and the broader CONCH / multimodal pathology agent line — and outlined where the field is going: larger tile encoders, multimodal (H&E + IHC + report + molecular) pretraining, agentic workflow composition, and clinical deployment. The talk is the direct methods-side complement to the AACR 2026 pathology-FM clinical-deployment readouts.

How it works / methodology

Pathology FMs share a three-tier stack: (1) self-supervised tile encoders (DINOv2-class) trained on tens-to-hundreds of millions of H&E patches; (2) slide-level aggregation (attention-based MIL, transformers over tile embeddings, set-transformer variants); (3) task heads for subtyping, biomarker prediction, survival, and weakly-supervised molecular regression. Mahmood-line models (UNI, CHIEF) emphasize generalization across cancer types via task-agnostic pretraining plus zero-shot / few-shot evaluation.

Headline benchmarks

TBD — keynote-level synthesis; specific benchmark deltas not in program-notes. CHIEF and UNI baselines remain the published anchors (CHIEF: 19 cancer types, 60K+ slides; UNI: >100M tiles).

How it works

Core idea. A pathology foundation model is a large image (and increasingly multimodal) encoder pretrained self-supervised on H&E whole-slide tiles at internet scale (tens-to-hundreds of millions of patches), producing a generic slide / tile embedding that transfers to dozens of downstream pathology tasks with minimal task-specific data.

Inputs / outputs. Inputs: H&E whole-slide images (typically 20x or 40x magnification); for multimodal extensions, paired IHC, molecular labels, or pathology reports. Outputs: tile-level embeddings (UNI, UNI2), slide-level embeddings or task predictions (CHIEF), or report / answer generation (multimodal pathology agents in the CONCH / PathChat line).

Key innovation. Three-tier stack with task-agnostic pretraining: (1) DINOv2-class self-supervised tile encoder pretrained on >100M unlabeled patches, (2) attention-MIL or transformer-over-tiles aggregator that lifts tile embeddings to slide-level representations, (3) light task heads or zero-shot evaluation. Generalization-by-scale rather than task-by-task model design is the field-shaping move; CHIEF added the agentic / multitask synthesis layer.

Parameters. UNI: ViT-L/16, ~300M parameters, ~100M H&E tiles. UNI2 / CHIEF v2: scale TBD (likely ViT-H/G, hundreds-of-millions to low-billions parameters, internet-scale tile counts). Slide-aggregation models: transformer over up to ~10K tiles per slide.

Canonical example. Zero-shot or few-shot lung-cancer subtyping from H&E: tile a WSI, encode all tiles with UNI, aggregate with attention-MIL, predict LUAD vs LUSC. CHIEF extends this to a single model covering 19 cancer types and 60K+ slides with prognostic outputs alongside diagnostic ones — the headline cross-cancer-type generalist pathology FM result that anchored the keynote.

Where it fits in the corpus

  • AACR 2026: direct line to CHIEF, UNI, and Prov-GigaPath dossiers
  • MICCAI 2026: anticipated COMPAY workshop cousin paper (Sep 27–Oct 1) — likely UNI2 or CHIEF v2 methods write-up
  • RSNA 2026 / CVPR 2026: RSNA radiology-pathology fusion track; CVPR FMV / MMFM-BIOMED workshops likely surface the same author pool

Notes

Keynote itself is not a tool page — any new model announced gets either (a) in-place update to the AACR dossier (incremental work) or (b) a new ISBI tool page if fundamentally new. Watch Mahmood Lab GitHub / HuggingFace through May–July 2026 for the artifact drop. Likely TBME Special Section pipeline if a methods companion paper exists.

FM comparison & 2026 status

Where it sits in the FM landscape. Mahmood's keynote is a survey / synthesis of the pathology foundation-model field, not a model release. The artifacts it discusses (UNI, UNI2, CHIEF, CONCH, KRONOS for spatial proteomics, the multimodal PathChat / CONCH agent line) are the underlying objects; the keynote's value is the landscape framing, the cross-model comparison, and the forward-look on multimodal pretraining + agentic deployment. Direct peers are therefore other pathology FM landscape surveys and individual pathology FMs — the keynote sits methodologically next to bioRxiv landscape reviews like "Understanding Foundation Models in Digital Pathology" (Sep 2025) and the EUCAIM / community clinical-benchmark efforts (clinical benchmark of public self-supervised pathology FMs, 2025).

Direct peers — pathology foundation models the keynote anchored.

Model Lab / Vendor Backbone Parameters Pretraining tiles / slides Released
UNI Mahmood Lab (Harvard / BWH) ViT-L/16 (DINOv2) ~300M ~100M H&E tiles Nature Medicine 2024
UNI2 Mahmood Lab ViT-H (DINOv2) larger than UNI 200M+ H&E + IHC tiles / 350K+ WSIs Jan 14 2025 release (UNI GitHub)
Virchow / Virchow2 Paige.ai ViT-H 632M (Virchow2) 1.7B tiles / 3.1M WSIs / 225K patients / 45 countries Virchow2 arXiv 2408.00738, 2024
CHIEF Mahmood Lab tile encoder + slide-level aggregator TBD 19 cancer types, 60K+ slides Nature 2024
Prov-GigaPath Microsoft Research / Providence ViT + LongNet slide-aggregator ~1B 1.3B tiles / 171K WSIs Nature 2024
Hibou HistAI ViT (DINOv2) tile encoder ~1B tiles 2024

UNI2 (Jan 2025) and Virchow2 (2024) are the most recent generation; UNI2 reports a perfect Balanced Accuracy (1.0) on BACH breast-cancer histology and 79.7 on pan-cancer tissue classification, while Virchow2 leads on CRC polyp classification (52.1) (UNI2 release notes). The keynote framed these as complementary rather than ranked — different backbones suit different downstream task families.

What changed in 2025–2026.

  • UNI2 release (Jan 14 2025) — 200M+ H&E and IHC tiles across 350K+ WSIs; 25K+ pre-extracted WSI embeddings released for TCGA, CPTAC, PANDA (Mahmood Lab GitHub).
  • Virchow2 (Paige.ai, 2024–2025) — scaling to 1.7B tiles and 3.1M WSIs from 225K patients; state-of-the-art on 12 tile-level tasks (Virchow2 paper).
  • CHIEF v2 / agentic-CHIEF (signposted in keynote). Methods companion paper expected through MICCAI 2026 / TBME pipeline — not yet released as of May 2026.
  • Clinical-benchmark traction. A clinical benchmark of public self-supervised pathology FMs (2025) is the first published head-to-head clinical comparison; complements but does not replace lab-internal benchmarks.
  • No retraction events affecting any of the named pathology FMs as of May 12 2026.

Cross-AACR relevance. Mahmood's keynote anchors a dense AACR 2026 cross-link cluster. The AACR bioinfo-tools landscape audit found 18 AACR 2026 posters citing pathology FMs by name — UNI / UNI2 (6 posters: #1441, #5470, #2758, #71, #4163, #5505), Lunit-SCOPE (2: #80, #1465), Virchow2 (1: #1442), Prov-GigaPath (1: #1470), plus CONCH, TITAN, H-optimus, CTransPath, Hibou, MUSK, DINOv2, KRONOS, LOKI, MADELEINE, CA-MAE as named encoders. Direct dossier links: AACR CHIEF, AACR UNI, AACR Prov-GigaPath. The relevant AACR 2026 sessions are Foundation Models & Multimodal AI in Cancer Research (Apr 17 PM), Decoding the Cancer Ecosystem: Pathology + TME Heterogeneity (Apr 20 AM), AI + Spatial Transcriptomics + Pathology (Apr 20 PM), and 3D Tissue Imaging and Cancer (Apr 18 PM). The existing AACR cross-synthesis synthesis-fm-pathology-traction.md is the page where Mahmood's ISBI keynote should be cited as the ground-truth landscape framing.